Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,354.80
(
0.49%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
93.82
(
-3.26%
)
Bitcoin
75,878.39
(
0.04%
)
News Focus
News Focus
Post# of 6306
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Perkin78

Send PM Follow Ignore
Followers 5
Posts 273
Boards Moderated 0
Alias Born 04/13/2013

Perkin78

Re: None

Tuesday, 07/30/2013 5:13:42 PM

Tuesday, July 30, 2013 5:13:42 PM

Post# of 6306
What do we make of this?

Form 8-K
Item 7.01 Regulation FD Disclosure.
InVivo Therapeutics Holdings Corp. (the “Company”) has announced that the process to up-list the Company’s common stock to a national securities exchange has been postponed indefinitely due to issues related to corporate governance.
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today